✦ LIBER ✦

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

✍ Scribed by Xavier M Mueller

Book ID: 116259092
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 110 KB
Volume: 77
Category: Article
ISSN: 0003-4975
DOI: 10.1016/j.athoracsur.2003.07.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug immunosuppression therapy for adult

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

✍ Xavier M Mueller 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 136 KB

PDB7 CLINICAL JUDGMENT OF DRUG THERAPY F

PDB7 CLINICAL JUDGMENT OF DRUG THERAPY FOR TYPE-2 DIABETES PATIENTS AND RESULTS OF HBA1C TESTS

✍ N Lipskiy 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Drug–drug interaction predictions with P

Drug–drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results

✍ Marylore Chenel; François Bouzom; Fanny Cazade; Kayode Ogungbenro; Leon Aarons; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 610 KB

[Progress in Brain Research] Functional

[Progress in Brain Research] Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I Volume 200 || Banking stem cells for research and clinical applications

✍ Stacey, Glyn 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 460 KB

This issue of *Progress in Brain Research* is split over 2 volumes, bringing together cutting-edge research on functional neural transplantation. The 2 volumes review current knowledge and understanding, provide a starting point for researchers and practitioners entering the field, and build a platf

Emerging Drugs and Targets for Alzheimer

Emerging Drugs and Targets for Alzheimer's Disease Volume 2 || Chapter 18. Possible Clinical Applications of Stem-Cell Strategies in AD Therapies

✍ Martinez, Ana 📂 Article 📅 2010 🏛 Royal Society of Chemistry ⚖ 151 KB

Treatment of Severe Relapsing-Remitting

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

✍ Nash, Richard; Hutton, George J.; Racke, Michael; Popat, Uday; Devine, Steven M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB